SYRS May 2024 5.000 call
| Previous Close | 0.4500 |
| Open | 0.4500 |
| Bid | 0.0000 |
| Ask | 0.5000 |
| Strike | 5.00 |
| Expire Date | 2024-05-17 |
| Day's Range | 0.4500 - 0.4500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 105 |
Business WireSyros to Participate in Upcoming Investor Conferences
CAMBRIDGE, Mass., May 07, 2024--Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that company management will participate in a fireside chat at two upcoming investor conferences. Details are as follows:
Business WireSyros to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
CAMBRIDGE, Mass., May 07, 2024--Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Tuesday, May 14, 2024 to report its first quarter 2024 financial results and provide a corporate update.
ZacksWill Femasys Inc. (FEMY) Report Negative Q1 Earnings? What You Should Know
Femasys (FEMY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
